Clinical Trials Directory

Trials / Unknown

UnknownNCT01597102

Cerebrovascular Autoregulation During and After Liver Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Johannes Gutenberg University Mainz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The cerebrovascular autoregulation (AR) is impaired in patients with hepatic encephalopathy. Patients with the indication to liver transplantation mostly have mild to severe hepatic encephalopathy. Transplantation should recover the encephalopathy. The aim of the study is to investigate the AR during liver transplantation, with the questions if the AR is impaired at the beginning of surgery and if there are changes in AR. For follow up the AR will be measured at the first days after transplantation at the ICU.

Detailed description

The cerebrovascular autoregulation (AR) will be measured using transcranial doppler and calculating the index of autoregulation Mx. This measurement is continuous with online calculation. So, the possible changes over the whole time of surgery can be detected. Furthermore, the measurement of AR at the ICU will be performed daily at the same time over a measurement period of 60 Minutes and the time course of AR after liver transplantation will be described.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionsNo intervention is planned in this study

Timeline

Start date
2012-01-08
Primary completion
2020-12-31
Completion
2021-03-31
First posted
2012-05-11
Last updated
2020-06-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01597102. Inclusion in this directory is not an endorsement.